Renal failure with fluoroquinolones

Therapie

Volumn 51, Issue 4, 1996, Pages 421-423

  Moore, N ^a   Breemeersch, C ^a   Noblet, C ^a  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; CONFERENCE PAPER; FEMALE; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; FEMALE; FLUOROQUINOLONES; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED;

EID: 0029778105     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Moore N, Biour M, Paux G et al. Adverse drug reaction monitoring: doing it the French Way. Lancet 1985; ii: 1056-1058.
2. Good pharmacovigilance practices. Paris: Agence du Médicament, 1994.
3. Vigeral P, Baumelou A, Benichou C, Castot A, Danan G, Kreft-Jais C et al. Les insuffisances rénales d'origine médicamenteuse, résultats de réunions de consensus. Nephrologie 1989; 10: 157-161.
4. Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments, actualisation de la méthode utilisée en France. Thérapie 1985; 40: 111-118.
5. Biour M, Moore N. Nephrotox. An updated database of drug induced kidney injury. Pharmacoepidemiol Drug Safety 1995; 4 (Suppl 1): S77.